- Home
- ELSE vs CANF Comparison
ELSE vs CANF Comparison
Compare ELSE & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- CANF
- Stock Information
- Founded
- ELSE 1968
- CANF 1994
- Country
- ELSE United States
- CANF Israel
- Employees
- ELSE N/A
- CANF N/A
- Industry
- ELSE Industrial Machinery/Components
- CANF Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- CANF Health Care
- Exchange
- ELSE Nasdaq
- CANF Nasdaq
- Market Cap
- ELSE 14.2M
- CANF 14.4M
- IPO Year
- ELSE N/A
- CANF N/A
- Fundamental
- Price
- ELSE $4.23
- CANF $1.95
- Analyst Decision
- ELSE
- CANF Strong Buy
- Analyst Count
- ELSE 0
- CANF 2
- Target Price
- ELSE N/A
- CANF $14.00
- AVG Volume (30 Days)
- ELSE 3.4K
- CANF 67.4K
- Earning Date
- ELSE 11-13-2024
- CANF 12-03-2024
- Dividend Yield
- ELSE N/A
- CANF N/A
- EPS Growth
- ELSE 26.54
- CANF N/A
- EPS
- ELSE 0.13
- CANF N/A
- Revenue
- ELSE $9,289,000.00
- CANF $667,000.00
- Revenue This Year
- ELSE N/A
- CANF $409.56
- Revenue Next Year
- ELSE N/A
- CANF N/A
- P/E Ratio
- ELSE $33.07
- CANF N/A
- Revenue Growth
- ELSE 11.21
- CANF N/A
- 52 Week Low
- ELSE $3.68
- CANF $1.87
- 52 Week High
- ELSE $4.40
- CANF $4.69
- Technical
- Relative Strength Index (RSI)
- ELSE 59.76
- CANF 35.20
- Support Level
- ELSE $4.03
- CANF $1.90
- Resistance Level
- ELSE $4.31
- CANF $2.21
- Average True Range (ATR)
- ELSE 0.09
- CANF 0.16
- MACD
- ELSE 0.02
- CANF -0.01
- Stochastic Oscillator
- ELSE 63.54
- CANF 10.42
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).